PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.\', \'Vitalant Research Institute, San Francisco, California.\', \'Westat, Rockville, Maryland.\', \'Creative Testing Solutions, Temple, Arizona.\', \'Scientific Affairs, American Red Cross, Rockville, Maryland.\', \'Scientific Affairs, American Red Cross, Gaithersburg, Maryland.\', \'New York Blood Center, New York.\', \'OneBlood, St Petersburg, Florida.\', \'Gulf Coast Regional Blood Center, Houston, Texas.\', \'Bloodworks Northwest, Seattle, Washington.\', \'Blood Bank of Hawaii, Honolulu.\', \'Carter BloodCare, Bedford, Texas.\', \'LifeSouth Community Blood Centers, Gainesville, Florida.\', \'Versiti, Milwaukee, Wisconsin.\', \'Blood Bank of Alaska, Anchorage.\', \'Banco de Sangre de Servicios Mutuos, San Juan, Puerto Rico.\', \'The Blood Center, New Orleans, Louisiana.\', \'LifeServe, Des Moines, Iowa.\', \'Innovative Blood Resources, St Paul, Minnesota.\', \'Georgia Tech Research Institute, Atlanta.\', \'University of British Columbia, Vancouver, British Columbia, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jama.2021.15161
?:doi
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 34473201
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all